SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +19.0% | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $58,000 | -28.4% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $81,000 | -22.9% | 14 | 0.0% | 0.00% | – |
| Q4 2021 | $105,000 | -16.7% | 14 | 0.0% | 0.00% | – |
| Q3 2021 | $126,000 | -25.0% | 14 | 0.0% | 0.00% | – |
| Q2 2021 | $168,000 | -4.0% | 14 | 0.0% | 0.00% | – |
| Q1 2021 | $175,000 | -19.7% | 14 | 0.0% | 0.00% | – |
| Q4 2020 | $218,000 | +65.2% | 14 | 0.0% | 0.00% | – |
| Q3 2020 | $132,000 | +5.6% | 14 | 0.0% | 0.00% | – |
| Q2 2020 | $125,000 | +40.4% | 14 | 0.0% | 0.00% | – |
| Q1 2020 | $89,000 | -23.9% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $117,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |